心脏损伤与COVID-19患者死亡及重症肺炎相关:一项荟萃分析
该研究为系统评价与荟萃分析,纳入13项研究共2389例COVID-19肺炎患者,探讨心脏损伤(定义依据纳入研究,包括高敏心肌肌钙蛋白I>99百分位)与死亡、需ICU治疗、ARDS及重症COVID-19的关联。结果显示,心脏损伤与死亡率升高相关(RR 7.95 [5.12, 12.34],p<0.001;I²=65%),与需ICU治疗相关(RR 7.94 [1.51, 41.78],p=0.01;I²=79%),与重症COVID-19相关(RR 13.81 [5.52, 34.52],p<0.001;I²=0%),但与ARDS风险无显著相关(RR 2.57 [0.96, 6.85],p=0.06;I²=84%)。发生主要+次要结局的患者hs-cTnI水平更高(平均差10.38 pg/mL [4.44, 16.32],p=0.002;I²=0%)。结论认为心脏损伤与COVID-19患者死亡、需ICU治疗及疾病严重程度相关。
要点
- COVID-19肺炎合并心脏损伤(hs-cTnI>99百分位)患者死亡风险显著升高(RR 7.95 [5.12, 12.34],p<0.001)。
- 心脏损伤与需ICU治疗风险升高相关(RR 7.94 [1.51, 41.78],p=0.01),置信区间宽,提示估计不精确。
- 心脏损伤与重症COVID-19风险升高相关(RR 13.81 [5.52, 34.52],p<0.001),异质性I²=0%。
- 心脏损伤与ARDS风险无显著相关(RR 2.57 [0.96, 6.85],p=0.06),异质性I²=84%。
- 发生主要+次要结局的患者hs-cTnI水平更高(平均差10.38 pg/mL [4.44, 16.32],p=0.002)。
适用人群与场景
- COVID-19肺炎患者,来自13项研究共2389例,纳入标准与排除标准依据各原始研究。
诊断标准与关键阈值
- 心脏损伤定义依据纳入研究,包括高敏心肌肌钙蛋白I(hs-cTnI)>99百分位。
- ARDS和重症COVID-19定义依据世界卫生组织(WHO)关于COVID-19严重急性呼吸道感染(SARI)的临时指南。
研究设计与关键结果
- 研究类型为系统评价与荟萃分析,纳入13项研究共2389例COVID-19肺炎患者。
- 心脏损伤与死亡率升高相关:RR 7.95(95%CI 5.12–12.34),p<0.001,I²=65%。
- 心脏损伤与需ICU治疗风险升高相关:RR 7.94(95%CI 1.51–41.78),p=0.01,I²=79%。
- 心脏损伤与重症COVID-19风险升高相关:RR 13.81(95%CI 5.52–34.52),p<0.001,I²=0%。
- 心脏损伤与ARDS风险无显著相关:RR 2.57(95%CI 0.96–6.85),p=0.06,I²=84%。
- 发生主要+次要结局的患者hs-cTnI水平更高:平均差10.38 pg/mL(95%CI 4.44–16.32),p=0.002,I²=0%。
证据类型、等级与局限
- 证据类型:系统评价与荟萃分析。
- 异质性:死亡结局I²=65%,需ICU治疗结局I²=79%,重症COVID-19结局I²=0%,ARDS结局I²=84%,hs-cTnI平均差I²=0%。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,心脏损伤与COVID-19患者死亡、需ICU治疗及疾病严重程度相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: In this systematic review and meta-analysis, we aimed to explore the association between cardiac injury and mortality, the need for intensive care unit (ICU) care, acute respiratory distress syndrome (ARDS), and severe coronavirus disease 2019 (COVID-19) in patients with COVID-19 pneumonia.
METHODS: We performed a comprehensive literature search from several databases. Definition of cardiac injury follows that of the included studies, which includes highly sensitive cardiac troponin I (hs-cTnl) >99th percentile.The primary outcome was mortality, and the secondary outcomes were ARDS, the need for ICU care, and severe COVID-19. ARDS and severe COVID-19 were defined per the World Health Organization (WHO) interim guidance of severe acute respiratory infection (SARI) of COVID-19.
RESULTS: There were a total of 2389 patients from 13 studies. This meta-analysis showed that cardiac injury was associated with higher mortality (RR 7.95 [5.12, 12.34], p < 0.001; I2: 65%). Cardiac injury was associated with higher need for ICU care (RR 7.94 [1.51, 41.78], p = 0.01; I2: 79%), and severe COVID-19 (RR 13.81 [5.52, 34.52], p < 0.001; I2: 0%). The cardiac injury was not significant for increased risk of ARDS (RR 2.57 [0.96, 6.85], p = 0.06; I2: 84%). The level of hs-cTnI was higher in patients with primary + secondary outcome (mean difference 10.38 pg/mL [4.44, 16.32], p = 0.002; I2: 0%).
CONCLUSION: Cardiac injury is associated with mortality, need for ICU care, and severity of disease in patients with COVID-19.
参考来源
- Santoso A, Pranata R, Wibowo A, et al. Cardiac injury is associated with mortality and critically ill pneumonia in COVID-19: A meta-analysis. Am J Emerg Med. 2020. PMID: 32331955. doi:10.1016/j.ajem.2020.04.052
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。